Medtronic (NYSE: MDT) announced today that it received CE mark approval for its Penditure LAA exclusion system.
WASHINGTON (March 19, 2017) -- For patients with atrial fibrillation (AFib), a common heart rhythm disorder, closing the area of the heart known as the left atrial appendage as an add-on procedure ...
The company plans to launch the device in Europe late next week, providing competition for AtriCure’s AtriClip product.
Please provide your email address to receive an email when new articles are posted on . OPTION is a head-to-head trial of left atrial appendage closure with Watchman FLX vs. anticoagulation after ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Left atrial appendage occlusion might be a treatment option for patients on dialysis with atrial fibrillation.
New partner reinforces confidence in the company's progress and future potential. NASHUA, N.H., Aug. 12, 2025 /PRNewswire/ -- Conformal Medical, Inc., a medical device company developing ...
No benefit in terms of prevention of ischemic stroke, transient ischemic attack and cardiovascular mortality after 1 year was observed when surgical left atrial appendage occlusion was performed in ...
Hosted on MSN
Lack of benefit from left atrial appendage occlusion for some patients after valvular surgery
No benefit in terms of prevention of ischemic stroke, transient ischemic attack and cardiovascular mortality after 1 year was observed when surgical left atrial appendage occlusion was performed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback